| Model Number |
OSC-4555 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Unspecified Infection (1930); Swelling/ Edema (4577)
|
| Date of Event |
02/15/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
It was verified that there are no other complaints or nonconformities related to the lot 2307022.Final release documentation of osc-4555, lot 2307022 was reviewed.Sterilization dose and dimensional and mechanical properties of the lot were within the specification.Tyvek- and aluminum seals of inspected pouches passed for the visual inspection.There are no customer complaints or nonconformities concerning sterility related to this sterilization lot.Based on the information inion has received, the patient's blood sugar control was poor, which was evaluated by the surgeon to be the cause of wound healing problems.The patient also suffered from hypertension grade 3, which may also cause wound healing problems.After debridement and antibiotic treatment, the local infection type symptoms disappeared and the wound healed.Bacterial infection is a surgery-related risk, and this risk always exists when surgery is being performed, regardless which type of fixation implants are used.This risk is increased if the patient suffers from diabetes-related poor glycemic control.The implantation site may be exposed to microbes both intraoperatively or postoperatively during wound healing period, which is often prolonged in cases of diabetic poor blood sugar control.In case of infection, biofilm can form on both metallic and biodegradable implants.Scientific publications have shown that the risk of bacterial infection is equal regardless of which type of implants are used (metal vs.Biodegradable).The implant material degradation related inflammatory tissue reactions can sometimes occur after using biodegradable implants but are usually seen much later when the biodegradable implants start to degrade, approximately 1-2 years after operation and lead to sterile local symptoms.The association of this incident to inion product is very unlikely, but with the information inion has received cannot be ruled out without a doubt.However, inion has not received any information of this incident that would implicate relevance to the inion device.Post market surveillance data gathered throughout the years of inion freedomscrew implants do not give reason to believe that the incident would be related to the bioabsorbable implant.
|
| |
|
Event or Problem Description
|
|
Based on the information received by inion, 38 year-old male patient suffering from type 2 diabetes had internal fixation with incision and reduction of right ankle fracture using inion freedomscrew¿ 4.5 x 55 mm, cannulated (osc-4555, lot 2307022).Surgery was performed under general anesthesia, the fracture of fibula was fixed with a bone grafting plate and the lower tibial fibula was fixed with resorbable screws, and the surgery was successfully completed and the patient discharged.1,5 months after the operation redness, swelling, and oozing of fluid appeared in the wound.The patient was admitted to the hospital for debridement, also antibiotics were given to prevent infection.The wound healed and patient was discharged.
|
| |
|
Search Alerts/Recalls
|
|